These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 32144299)
1. Identification of the key genes and pathways involved in the tumorigenesis and prognosis of kidney renal clear cell carcinoma. Cui H; Shan H; Miao MZ; Jiang Z; Meng Y; Chen R; Zhang L; Liu Y Sci Rep; 2020 Mar; 10(1):4271. PubMed ID: 32144299 [TBL] [Abstract][Full Text] [Related]
2. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma. Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive characterization of immune- and inflammation-associated biomarkers based on multi-omics integration in kidney renal clear cell carcinoma. Zhao E; Li L; Zhang W; Wang W; Chan Y; You B; Li X J Transl Med; 2019 May; 17(1):177. PubMed ID: 31133033 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma. Lin S; Zheng L; Lu Y; Xia Q; Zhou P; Liu Z Cancer Med; 2020 Nov; 9(22):8624-8638. PubMed ID: 32970930 [TBL] [Abstract][Full Text] [Related]
5. Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma. Song J; Peng J; Zhu C; Bai G; Liu Y; Zhu J; Liu J Cell Physiol Biochem; 2018; 48(6):2549-2562. PubMed ID: 30121668 [TBL] [Abstract][Full Text] [Related]
6. Correlating Transcriptional Networks to Papillary Renal Cell Carcinoma Survival: A Large-Scale Coexpression Analysis and Clinical Validation. Feng X; Zhang M; Meng J; Wang Y; Liu Y; Liang C; Fan S Oncol Res; 2020 May; 28(3):285-297. PubMed ID: 31948514 [TBL] [Abstract][Full Text] [Related]
7. A Gene Signature of Survival Prediction for Kidney Renal Cell Carcinoma by Multi-Omic Data Analysis. Hu F; Zeng W; Liu X Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739630 [TBL] [Abstract][Full Text] [Related]
8. Identification of genes and pathways involved in kidney renal clear cell carcinoma. Yang W; Yoshigoe K; Qin X; Liu JS; Yang JY; Niemierko A; Deng Y; Liu Y; Dunker A; Chen Z; Wang L; Xu D; Arabnia HR; Tong W; Yang M BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S2. PubMed ID: 25559354 [TBL] [Abstract][Full Text] [Related]
9. Expression of BAG1 is associated with prognosis in kidney renal clear cell carcinoma based on bioinformatics. Wu H; Liu M; He Y; Meng G; Guo W; Guo Q BMC Cancer; 2021 Feb; 21(1):160. PubMed ID: 33581726 [TBL] [Abstract][Full Text] [Related]
10. Identification of a Set of Genes Improving Survival Prediction in Kidney Renal Clear Cell Carcinoma through Integrative Reanalysis of Transcriptomic Data. Ruan B; Feng X; Chen X; Dong Z; Wang Q; Xu K; Tian J; Liu J; Chen Z; Shi W; Wang M; Qian L; Ding Q Dis Markers; 2020; 2020():8824717. PubMed ID: 33110456 [TBL] [Abstract][Full Text] [Related]
11. An integrated analysis of cancer genes in clear cell renal cell carcinoma. Li J; Guo L; Ai Z Future Oncol; 2017 Apr; 13(8):715-725. PubMed ID: 28266251 [TBL] [Abstract][Full Text] [Related]
12. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening. Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208 [TBL] [Abstract][Full Text] [Related]
13. The promising novel biomarkers and candidate small molecule drugs in kidney renal clear cell carcinoma: Evidence from bioinformatics analysis of high-throughput data. Zhang B; Wu Q; Wang Z; Xu R; Hu X; Sun Y; Wang Q; Ju F; Ren S; Zhang C; Qin L; Ma Q; Zhou YL Mol Genet Genomic Med; 2019 May; 7(5):e607. PubMed ID: 30793530 [TBL] [Abstract][Full Text] [Related]
14. NR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1/2-YAP signaling. Yin L; Li W; Wang G; Shi H; Wang K; Yang H; Peng B J Exp Clin Cancer Res; 2019 Aug; 38(1):343. PubMed ID: 31391070 [TBL] [Abstract][Full Text] [Related]
15. Dichotomous roles of ADAR1 in liver hepatocellular carcinoma and kidney renal cell carcinoma: Unraveling the complex tumor microenvironment and prognostic significance. Mao JX; Li JJ; Lu XY; Zhong HX; Zhao YY; Zhu LY; Fu H; Ding GS; Teng F; Chen M; Guo WY Int Immunopharmacol; 2024 Jul; 136():112340. PubMed ID: 38820962 [TBL] [Abstract][Full Text] [Related]
16. Autophagy-related gene Xie L; Li H; Zhang L; Ma X; Dang Y; Guo J; Liu J; Ge L; Nan F; Dong H; Yan Z; Guo X Aging (Albany NY); 2020 Jan; 12(2):1828-1842. PubMed ID: 32003756 [TBL] [Abstract][Full Text] [Related]
17. The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma. Bai S; Wu Y; Yan Y; Kang H; Zhang J; Ma W; Gao Y; Hui B; Li R; Zhang X; Ren J Int J Med Sci; 2020; 17(18):2917-2925. PubMed ID: 33173412 [No Abstract] [Full Text] [Related]
18. Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinoma. Cui Y; Yan M; Zhang C; Xue J; Zhang Q; Ma S; Guan F; Cao W J Cancer Res Clin Oncol; 2020 Aug; 146(8):1993-2006. PubMed ID: 32444962 [TBL] [Abstract][Full Text] [Related]
19. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma. Xing Q; Ji C; Zhu B; Cong R; Wang Y Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567 [TBL] [Abstract][Full Text] [Related]
20. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis. Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]